NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
RSS Feed for NewMediaWireNovember 13, 2026 — LOS ANGELES, CA - November 13, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer.
November 13, 2026 — BOCA RATON, FL - November 13, 2026 (NEWMEDIAWIRE) - Vycor Medical, Inc. (“Vycor”) (OTCQB-VYCO), today announced financial results for the three and nine months ended September 30, 2026.
November 13, 2026 — HOUSTON, TX - November 13, 2026 (NEWMEDIAWIRE) - AI-driven protein design is accelerating the discovery of novel protein binders, but experimental validation remains essential to determine whether computational designs translate into meaningful target interactions. To bridge this gap, Sino Biological, Inc.
November 13, 2026 — DELTA, UT - November 13, 2026 (NEWMEDIAWIRE) - Ares Strategic Mining Inc. (CSE: ARS) (OTCQX: ARSMF) (FRA: N811) ("Ares" or the "Company") is pleased to announce it is now producing metallurgical-grade fluorspar (“metspar”) lumps at saleable grade, meeting the customer specifications targeted for the Company’s initial deliveries.
November 13, 2026 — By Meg Flippin, Benzinga DETROIT, MICHIGAN - November 12, 2026 (NEWMEDIAWIRE) - The Federal Reserve left interest rates unchanged during its October meeting, but that doesn’t mean everyone was in agreement. There was dissent among officials, with two Fed officials preferring a quarter-point raise.
November 12, 2026 — DUSSELDORF, GERMANY - November 12, 2026 (NEWMEDIAWIRE) - The Supervisory Board of GEA Group AG today resolved on a leadership change at the helm of the company as well as related changes in the composition of the Executive Board. Stefan Klebert (61), CEO of GEA, will step down from his position at his own request and by mutual agreement with the Supervisory Board following the conclusion of the 2027 Annual General Meeting on April 28, 2027.
November 12, 2026 — Customer contracts: + 770,000 to 30. 49 million contracts Sales: + 3.
November 12, 2026 — New AI Agent Studio simplifies development of bespoke AI agents and intelligent process automation NFON continues to develop its AI business consistently towards a solutions- and platform-based model European partner network supports marketing and scaling of custom AI solutions MUNICH, GERMANY - November 12, 2026 (NEWMEDIAWIRE) - NFON AG (FSE: NFN), a leading European provider of integrated business communications with a focus on AI-based applications, is advancing its AI solution portfolio with its AI Agent Studio and thereby strengthening its offering in intelligent process automation. This solution complements the existing visual approach to building AI applications with a conversational approach, making it easier for SMEs in particular to get started with developing customised AI agents and automating business processes.
November 12, 2026 — Planned study in Abu Dhabi combines genetic analysis with personalized nutrient supplementation for GLP-1 therapies As part of the planned study, Novogenia will conduct DNA analyses, evaluate the results, and develop and produce personalized dietary supplements The study design initially calls for 500 participants in Abu Dhabi The 10XREVIV initiative is part of Novogenia’s international growth strategy MUNICH, GERMANY - November 12, 2026 (NEWMEDIAWIRE) - Novogenia AG (ticker symbol: 7V0), an international healthcare company focused on human genetics and the development of personalized products based on genetic insights, announces its exclusive participation as a technology and manufacturing partner in a planned clinical study as part of the 10XREVIV initiative in Abu Dhabi, United Arab Emirates. For the study, Novogenia will conduct and evaluate DNA analyses and develop and manufacture personalized dietary supplements for study participants derived from the results.
November 12, 2026 — Consolidated revenue rises by 8. 1% to EUR 2.
November 12, 2026 — LOS ANGELES, CA - November 12, 2026 (NEWMEDIAWIRE) - Mobilicom (NASDAQ: MOB), a provider of cybersecure solutions for drones and robotics, announced that it has engaged a U. S.
November 12, 2026 — HONG KONG - November 12, 2026 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council (HKTDC)'s Chairman, Professor Frederick Ma, just completed a high-level Hong Kong business delegation to the technology powerhouse of the Chinese Mainland, Hefei in Anhui Province, to explore collaboration in innovation and technology, covering research and development, marketisation and industry development opportunities. Comprising over 30 members from the Hong Kong SAR Government, science and technology parks, major chambers of commerce, universities and research institutions, the delegation received a warm official reception from Anhui Acting Governor Wang Dongwei, Anhui Vice Governor Sun Yong and Hefei Mayor Zhang Quan.
November 12, 2026 — Supported by a 20-Year Facility Management Rights Agreement, This Expansion is Part of the Group's Accelerated Business Transformation and Diversification, in Line With Consolidated Revenue Growth of 13. 2% Through September 2026 MUSCAT, OMAN - November 12, 2026 (NEWMEDIAWIRE) - Garuda Indonesia Group continues to strengthen its international business expansion through the launch of Oman GMF Technic, a joint venture between PT Garuda Maintenance Facility Aero Asia Tbk (GMF) and Oman Air, which took place at Muscat International Airport, Sultanate of Oman, on Tuesday (November 10).
November 12, 2026 — Fund Indicates Intent to Purchase Common Stock Over Time Following SEC Qualification; Management Believes Raising Capital in Stages may Help Manage Dilution TULSA, OK - November 12, 2026 (NEWMEDIAWIRE) - Ladybug Resource Group, Inc. (OTC: LBRG) ("Ladybug" or the "Company") today announced that it has entered into a non-binding letter of intent, dated November 6, 2026 and countersigned by the Company on November 9, 2026, with a New Jersey-based private fund and accredited investor (the "Investor").
November 12, 2026 — From Javier Sanguino García, Chairman of the Board and Chief Executive Officer MIAMI, FL - November 12, 2026 (NEWMEDIAWIRE) - To our fellow shareholders, I want to introduce myself directly and speak plainly about where this company stands and where we intend to take it. My name is Javier Sanguino García, and I have taken the roles of Chairman of the Board and Chief Executive Officer of Unique Global Innovative Solutions Corporation (OTC: UGIZ) in connection with the change of control, which was executed and announced on November 6, 2026, and filed with OTC Markets on November 11, 2026.
November 12, 2026 — SASKATOON, SK - November 12, 2026 (NEWMEDIAWIRE) - Omineca Mining and Metals Ltd. (TSXV: OMM) (“Omineca” or the “Company”) is pleased to announce that it has entered into a binding letter of intent (the "Agreement") with HMI Mining ("HMI") to acquire a 50% interest in the Company's Wingdam Placer Project (the "Project").
November 12, 2026 — VANCOUVER, B. C - November 12, 2026 (NEWMEDIAWIRE) - Centenario Gold Corp.
November 12, 2026 — TORONTO, ON - November 12, 2026 (NEWMEDIAWIRE) - Silver Crown Royalties Inc. (Cboe: SCRI, OTCQX: SLCRF, BF: QS0) ("Silver Crown", "SCRi", the "Corporation", or the "Company") is pleased to announce a non-brokered private placement of common shares of the Corporation ("Common Shares") for gross proceeds of up to approximately C$5,000,000 (the "Offering").
November 11, 2026 — Group revenue of EUR 49. 8 million and adjusted EBIT of EUR 15.
November 11, 2026 — BASEL, SWITZERLAND - November 11, 2026 (NEWMEDIAWIRE) - BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria, announced today that it will present new data on alpibectir together with its development partner GSK. The Union World Conference on Lung Health is taking place from 17 to 20 November 2026 in Rio de Janeiro, Brazil.